MedTrace Logo

Familial Aggregation and Biomarkers in REM Sleep Behaviour Disorder.

NCT03660982 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-08-06

No results posted yet for this study

Summary

In this cohort study, the investigators aim to study the familial aggregation of REM sleep behavior disorder (RBD) and compare the differences in major biomarkers of neurodegeneration, including percentage of EMG activity during REM sleep, cognitive functions, autonomic dysfunction, and psychiatric disorders, between unaffected first degree relatives of RBD cases and non-RBD controls.

Conditions

  • REM Sleep Behavior Disorder

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Jihui Zhang, PhD · Chinese University of Hong Kong

  • Yun Kwok Wing, MBChB · Chinese University of Hong Kong

  • Siuping LAM · Chinese University of Hong Kong

  • Vicent Chung-tong MOK · Chinese University of Hong Kong

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03660982 on ClinicalTrials.gov